@antibotter says....
AstraZeneca has not began phase 2 of the seamless phase 1/2 clinical trial of AZD0466 yet
JF & Co. state in the December 2021 Shareholder Newsletter dated 16 Dec 2021 and again in the recent Quarterly report issued on 28 January 2022 the complete opposite ?
Content from Shareholder Newsletter Dec 2021
Who to believe I wonder given the phase 1 trial has finished and JF & Co. state as recent as December and again in January that they are "actively enrolling patients" ? lol
Content from Quarterly Jan 2022
I also wonder if the 100 years of commercial experience was smart enough to secure additional upfront milestone payments in the AstraZeneca agreement when a new trial is started using the same drug ... for example; AZD0466
Are Starpharma entitled to another milestone payment for this new trial starting this month (Feb) if it is the same DEP drug already being trialed for a different treatment or will AstraZeneca be able to say yeah, nah ... no money for you as it is the same indication ??
- Forums
- ASX - By Stock
- SPL
- Next key milestone payment
Next key milestone payment, page-2
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.001(1.06%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.6¢ | 9.7¢ | 9.5¢ | $1.207K | 12.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7755 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 13402 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7755 | 0.094 |
4 | 81828 | 0.093 |
1 | 247718 | 0.092 |
2 | 50000 | 0.091 |
1 | 30000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 13402 | 4 |
0.097 | 17393 | 2 |
0.098 | 19848 | 1 |
0.099 | 7058 | 2 |
0.100 | 50000 | 1 |
Last trade - 11.06am 04/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online